Posted by Michael Wonder on 01 Mar 2022
Glucophage is the first oral diabetes treatment approved in Europe for use during pregnancy
28 February 2022 - The approval was granted on the basis of Merck’s own safety cohort study CLUE and a large body of published evidence.
Merck today announced in a European worksharing procedure an extension to the label for metformin products in the EU - Glucophage (metformin hydrochloride immediate release), Glucophage XR (metformin hydrochloride extended release) and Stagid (metformin embonate immediate release) - for use throughout pregnancy.
